Puts Purchased on ViroPharma Incorporated (VPHM)

Shares of ViroPharma Incorporated VPHM are lower on the session by 9.67%, currently trading at $19.70. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short while ago the November $20.00 put was purchased 1,000 times, on the offer, on open interest of 107 contracts. Overall put volume is now running at 11.98x the daily average with 99% of all puts traded being purchases on the offer. ViroPharma Incorporated is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. It has two marketed products and two development programs.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Short IdeasTechnicalsOptionsTrading IdeasHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!